Drug or treatment
Sarilumab clinical trials
As of November 12, 2026, Find a Trial lists 5 clinical trials of Sarilumab that are recruiting, at sites in 19 countries (most in United States (4), Canada (2), France (2)). By phase: Phase 1/2 (2), Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 19Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| IV sarilumab for adults with rheumatoid arthritis | Phase 1/2 | Centennial, Colorado and 11 other locations | Recruiting | Jul 15, 2026 |
| Sarilumab for early polymyalgia rheumatica in adults | Phase 3 | Avondale, Arizona and 84 other locations | Recruiting | Dec 16, 2025 |
| Combining Sarilumab with Other Treatments for Advanced Melanoma | Phase 2 | Los Angeles, California and 3 other locations | Recruiting | Jun 22, 2022 |
| Combining Sarilumab with Capecitabine for Treating Triple Negative Breast Cancer | Phase 1/2 | Los Angeles, California and 2 other locations | Recruiting | Apr 3, 2020 |
| Finding the right dose of sarilumab for children with systemic juvenile idiopathic arthritis | Phase 2 | San Miguel de Tucumán, Tucumán Province and 39 other locations | Recruiting | Dec 13, 2016 |
All recruiting trials (5)
-
IV sarilumab for adults with rheumatoid arthritis
This study tests IV sarilumab to see how it works and how safe it is for adults with moderately to severely active rheumatoid arthritis, with or without certain standard arthritis medicines.
-
Sarilumab for early polymyalgia rheumatica in adults
This study tests whether sarilumab given every two weeks, with a prednisone taper, helps people with early polymyalgia rheumatica more than placebo plus prednisone taper.
-
Combining Sarilumab with Other Treatments for Advanced Melanoma
This study is testing a new combination of treatments for people with advanced melanoma to see if it helps them feel better and live longer.
-
Combining Sarilumab with Capecitabine for Treating Triple Negative Breast Cancer
This study is testing if combining an immunotherapy drug called sarilumab with a chemotherapy drug called capecitabine can help people with advanced triple negative breast cancer or those who still have high-risk disease after initial treatment.
-
Finding the right dose of sarilumab for children with systemic juvenile idiopathic arthritis
This study is testing the right dose of sarilumab to see how well it works and how safe it is for children and teens with systemic juvenile idiopathic arthritis.
Quick answers
How many clinical trials of Sarilumab are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 19 countries. The most sites are in United States (4 trials), Canada (2 trials), France (2 trials), Germany (2 trials), Greece (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.